CN1301665C - Blood fat-regulating liver-protecting health food - Google Patents
Blood fat-regulating liver-protecting health food Download PDFInfo
- Publication number
- CN1301665C CN1301665C CNB2005100706805A CN200510070680A CN1301665C CN 1301665 C CN1301665 C CN 1301665C CN B2005100706805 A CNB2005100706805 A CN B2005100706805A CN 200510070680 A CN200510070680 A CN 200510070680A CN 1301665 C CN1301665 C CN 1301665C
- Authority
- CN
- China
- Prior art keywords
- health food
- blood fat
- liver
- extract
- red yeast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008280 blood Substances 0.000 title claims abstract description 17
- 210000004369 blood Anatomy 0.000 title claims abstract description 17
- 235000013402 health food Nutrition 0.000 title claims abstract description 15
- 229940026314 red yeast rice Drugs 0.000 claims abstract description 14
- 229940046374 chromium picolinate Drugs 0.000 claims abstract description 12
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000020727 milk thistle extract Nutrition 0.000 claims description 11
- 229940096421 milk thistle extract Drugs 0.000 claims description 11
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 claims description 8
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 claims description 8
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 claims description 8
- 229960004844 lovastatin Drugs 0.000 claims description 8
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 claims description 8
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 claims description 7
- 229960004245 silymarin Drugs 0.000 claims description 7
- 235000017700 silymarin Nutrition 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 11
- 210000004185 liver Anatomy 0.000 abstract description 9
- 235000010841 Silybum marianum Nutrition 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract 2
- 244000272459 Silybum marianum Species 0.000 abstract 1
- 230000003203 everyday effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 2
- 241000320380 Silybum Species 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- SEBFKMXJBCUCAI-DBMPWETRSA-N silybin Chemical compound C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-DBMPWETRSA-N 0.000 description 2
- FDQAOULAVFHKBX-KMRPREKFSA-N (+)-Isosilybin A Natural products C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC(=CC=C3O2)[C@@H]2[C@@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-KMRPREKFSA-N 0.000 description 1
- FDQAOULAVFHKBX-HKTJVKLFSA-N (2r,3r)-3,5,7-trihydroxy-2-[(2r,3r)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC(=CC=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-HKTJVKLFSA-N 0.000 description 1
- SEBFKMXJBCUCAI-WAABAYLZSA-N (2r,3r)-3,5,7-trihydroxy-2-[(2s,3s)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-WAABAYLZSA-N 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- KDMGQPNVTKUNHV-UHFFFAOYSA-N Isosilybin Natural products C1=C(O)C(OC)=CC=C1C1C(CO)OC2=CC=C(C3C(C(=O)C4=C(O)C=C(O)C=C4O3)O)C=C2O1 KDMGQPNVTKUNHV-UHFFFAOYSA-N 0.000 description 1
- FDQAOULAVFHKBX-UHFFFAOYSA-N Isosilybin A Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC(=CC=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-UHFFFAOYSA-N 0.000 description 1
- CYGIJEJDYJOUAN-UHFFFAOYSA-N Isosilychristin Natural products C1=C(O)C(OC)=CC(C2C3C=C(C4C(C3=O)(O)OCC42)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 CYGIJEJDYJOUAN-UHFFFAOYSA-N 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- RIAZZJBPJQWPIS-UHFFFAOYSA-N Silychristin Natural products COc1cc(ccc1O)C2OC3C(C=C(C=C3O)C4Oc5cc(O)cc(O)c5C(=O)C4O)C2CO RIAZZJBPJQWPIS-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- BFGKITSFLPAWGI-UHFFFAOYSA-N chromium(3+) Chemical compound [Cr+3] BFGKITSFLPAWGI-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 231100000334 hepatotoxic Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- BMLIIPOXVWESJG-LMBCONBSSA-N silychristin Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@@H](C3=C(C(=CC(=C3)[C@@H]3[C@H](C(=O)C4=C(O)C=C(O)C=C4O3)O)O)O2)CO)=C1 BMLIIPOXVWESJG-LMBCONBSSA-N 0.000 description 1
- BMLIIPOXVWESJG-UHFFFAOYSA-N silychristin A Natural products C1=C(O)C(OC)=CC(C2C(C3=C(C(=CC(=C3)C3C(C(=O)C4=C(O)C=C(O)C=C4O3)O)O)O2)CO)=C1 BMLIIPOXVWESJG-UHFFFAOYSA-N 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
The present invention discloses the health food for regulating blood fat and protecting liver, which is characterized in that the health food is composed of components of the following proportion by weight: 10 to 75% of red yeast rice extraction, 1.8 to 45% of Carduus marianus extraction and 0.01 to 0.5% of chromium picolinate. The health food has the effects on regulating the blood fat and protecting the liver.
Description
Technical field
The present invention relates to a kind of health food, is a kind of health food of regulating blood fat and liver protection effect that has specifically.
Background technology
Because the increase of operating pressure and life stress, and the quickening of rhythm of life and growth in the living standard, people spend the time in working and learning more and more longer, and have sports and to carry out time of other motion fewer and feweri, life improves the unreasonable of back dietary structure in addition, cause people's physique level descending, make the continuous increase of obese people and human immunity the trend that reduces occur, thereby blood fat can occur increases, even atherosclerotic etc. appears, in addition, fatty liver, alcoholic liver patient also is increase trend, makes sub-health population in continuous increase.
Summary of the invention
The object of the present invention is to provide a kind of blood fat-regulating liver-protecting health food, this health food has certain adjusting blood fat and to health care, the protective effect of liver.
Adjusting blood fat liver-protecting health food provided by the invention, contain red yeast rice extract and milk thistle extract and chromium picolinate, wherein the red yeast rice extract is 0.04～20% in its weight percentage of Lovastatin, milk thistle extract is 0.4～10% in its weight content of silymarin, and chromium picolinate is 0.01～0.5%.
Preferred mode is to contain the component of following weight content: the red yeast rice extract counts 0.2% with Lovastatin, milk thistle extract with silymarin count 2%, chromium picolinate 0.042%.
Contain Lovastatin and some other composition in the red yeast rice extract, effect with reducing blood lipid, reduction T-CHOL, Lovastatin content can reach 1.5% in the red yeast rice extract of buying in the market, and the effect of red yeast rice extract is better than Lovastatin, not only safety but also have no side effect.
Milk thistle is the seed of feverfew milk thistle, and milk thistle extract contains silymarin, silymarin mainly by legalon, Isosilybin, Silychristin, to fly the water Ji peaceful etc.Studies show that silymarin can resist the infringement of Hepatoxic substance to liver to the liver protective effect, promote the reparation and the regeneration of liver plasma membrane, effect of anti hepatic fibrosis; Also have Green Tea Extract activity, effect for reducing blood fat, lipoid peroxidization resistant, the effect of lipotropism oxygenase in addition.
Chromium (III) participates in the glycometabolism in the body, is to keep the normal glucose tolerance of body, growth and indispensable trace element of life-span.Chromium picolinate is a kind of sensitizer of insulin, can reduce the opposing behind insulin receptor and the acceptor, helps preventing and treating the generation of diabetes and insuline resistance syndrome.
This blood fat-regulating liver-protecting health food of the present invention, owing to added red yeast rice extract, milk thistle extract, chromium picolinate with health role, select by reasonable and science its consumption, utilize the collaborative health-care effect of three kinds of compositions, make this health food have the effect and the effect of liver protecting and reducing blood lipid, especially be fit to have the people of liver diseases and diabetes, high fat of blood or health, sub-health population health care to use.
The specific embodiment
Below in conjunction with specific embodiment blood fat-regulating liver-protecting health food of the present invention is described further.
Embodiment 1
Raw materials usedly be: the commercially available red yeast rice extract that contains 200 milligrams of Lovastatins 50 grams, commercially available moisture milk thistle extract 9 grams, chromium picolinate 0.042 gram, cornstarch 40.958 grams that fly silibin 2 grams, it is encapsulated that porphyrize mixes the back, adorns 0.65 gram for every.
Using method is: every day 2 times, each 2-3 grain.
Embodiment 2
Raw materials usedly be: the commercially available red yeast rice extract that contains 40 milligrams of Lovastatins 10 grams, commercially available moisture milk thistle extract 45 grams, chromium picolinate 0.01 gram, beta-schardinger dextrin-44.99 grams that fly silibin 10 grams, make tablet, every weight is 0.65 gram.
Using method is: every day 2 times, each 2-3 sheet.
Embodiment 3
Raw materials usedly be: the commercially available red yeast rice extract that contains Lovastatin 20 grams 75 grams, commercially available moisture milk thistle extract 1.8 grams, chromium picolinate 0.5 gram, cornstarch and the polyvinylpyrrolidone (PVP) that flies 400 milligrams of silibins are in right amount, make 100 gram tablets, every weight is 0.65 gram.
Eating method is: every day 2 times, each 2-3 sheet.
Claims (2)
1, a kind of adjusting blood fat liver-protecting health food, it is characterized in that containing red yeast rice extract and milk thistle extract and chromium picolinate, wherein the red yeast rice extract is 0.04～20% in its weight percentage of Lovastatin, milk thistle extract is 0.4～10% in its weight content of silymarin, and chromium picolinate is 0.01～0.5%.
2, adjusting blood fat liver-protecting health food as claimed in claim 1, it is characterized in that containing the component of following weight content: the red yeast rice extract counts 0.2% with Lovastatin, milk thistle extract with silymarin count 2%, chromium picolinate 0.042%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100706805A CN1301665C (en) | 2005-05-18 | 2005-05-18 | Blood fat-regulating liver-protecting health food |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100706805A CN1301665C (en) | 2005-05-18 | 2005-05-18 | Blood fat-regulating liver-protecting health food |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1672574A CN1672574A (en) | 2005-09-28 |
| CN1301665C true CN1301665C (en) | 2007-02-28 |
Family
ID=35045545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100706805A Expired - Fee Related CN1301665C (en) | 2005-05-18 | 2005-05-18 | Blood fat-regulating liver-protecting health food |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1301665C (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101062097B (en) * | 2007-06-11 | 2011-05-04 | 毛晓敏 | Compound for improving and treating fatty liver |
| CN101647845B (en) * | 2008-08-13 | 2011-11-30 | 张晶 | Natural product composition used for reducing blood fat and preparation method thereof |
| CN101986860B (en) * | 2009-08-07 | 2013-08-28 | 上海宏威生物科技有限公司 | Composite premixed feed for livestock and poultry and preparation method thereof |
| CN103110103A (en) * | 2013-03-13 | 2013-05-22 | 广州朗姿贸易有限公司 | Nutritious food powder for clearing fat and losing weight |
| CN104435147A (en) * | 2014-12-08 | 2015-03-25 | 南京泛成生物化工有限公司 | Composition for preventing and treating non-alcoholic fatty liver disease and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1336193A (en) * | 2000-07-31 | 2002-02-20 | 雷学军 | Antilipenic functional water containing natural medicine component and its compounding process |
| CN1380067A (en) * | 2002-04-29 | 2002-11-20 | 池寒峰 | Medicine with functions of reducing sugar and reducing blood-fat and its preparation method |
| CN1394520A (en) * | 2001-07-11 | 2003-02-05 | 北京万博力科技发展有限公司 | Method for producing sugar-reducing soluble granules richly containing alpha-linolenic acid, lecithin and trivalent chromium |
| CN1539416A (en) * | 2003-04-21 | 2004-10-27 | 山东省中医药研究院 | Medication for treating acute hepatitis and chronic hepatitis and preparation technique |
| CN1557370A (en) * | 2004-01-16 | 2004-12-29 | 石家庄金汉方生物科技开发有限公司 | Antihyperglycemic and oxidation resistant health products and preparing process thereof |
-
2005
- 2005-05-18 CN CNB2005100706805A patent/CN1301665C/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1336193A (en) * | 2000-07-31 | 2002-02-20 | 雷学军 | Antilipenic functional water containing natural medicine component and its compounding process |
| CN1394520A (en) * | 2001-07-11 | 2003-02-05 | 北京万博力科技发展有限公司 | Method for producing sugar-reducing soluble granules richly containing alpha-linolenic acid, lecithin and trivalent chromium |
| CN1380067A (en) * | 2002-04-29 | 2002-11-20 | 池寒峰 | Medicine with functions of reducing sugar and reducing blood-fat and its preparation method |
| CN1539416A (en) * | 2003-04-21 | 2004-10-27 | 山东省中医药研究院 | Medication for treating acute hepatitis and chronic hepatitis and preparation technique |
| CN1557370A (en) * | 2004-01-16 | 2004-12-29 | 石家庄金汉方生物科技开发有限公司 | Antihyperglycemic and oxidation resistant health products and preparing process thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1672574A (en) | 2005-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Agunbiade et al. | Hypoglycaemic activity of Commelina africana and Ageratum conyzoides in relation to their mineral composition | |
| Sharma et al. | Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes | |
| JP2012500201A5 (en) | ||
| CN1301665C (en) | Blood fat-regulating liver-protecting health food | |
| CN101642152A (en) | Assistant hypoglycemic healthcare biscuits | |
| Aliyu et al. | Daily consumption of honey: effects on male wister albino rats | |
| CN102422950B (en) | Hordeum vulgare L. var. nudum hook. f. health tea drink and its processing technology | |
| CN106047560A (en) | Preparation method of tartary buckwheat rice wine | |
| CN106819854A (en) | A kind of barley young leaf composite powder and preparation method thereof | |
| CN103355619B (en) | Fructus phyllanthi and Radix Puerariae health food | |
| WO2021203661A1 (en) | Seaweed fruit and vegetable formula for assisting in reducing fat and losing weight | |
| CN101019895B (en) | Health product for reducing blood sugar and its prepn | |
| CN106720834A (en) | A kind of alcohol detoxication candies and preparation method thereof | |
| CN1319544C (en) | Tea-ginseng capsule | |
| JP2010030950A (en) | Prophylactic and therapeutic agent for metabolic syndrome and functional food | |
| JP2007031302A (en) | Adiponectin production accelerator and metabolic syndrome preventive | |
| CN1323686C (en) | Detoxifying sobering up tea and its production method | |
| CN106262569A (en) | A kind of nutraceutical of three-hypers patient | |
| KR101054808B1 (en) | Composition for improving cholesterol containing poly-gamma glutamic acid | |
| CN1082353C (en) | Biological fungus beverage containing saussurea involucrata | |
| CN1826972A (en) | Health-caring product capable of reducing blood sugar | |
| Okonkwo et al. | Hypoglycaemic effects of the aqueous extract of Newbouldia laevis root in rats | |
| Zhao et al. | Long-term feeding of sand rice (Agriophyllum squarrosum seed) can improve the antioxidant capacity of mice | |
| CN1256883A (en) | Sugar reducing pumpkin nutrient flour | |
| KR20170085912A (en) | Toppokki sause containing extract of Mori Cortex Radicis and manufacturing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HUNAN THEIL PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: CHENG GANG Effective date: 20080328 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20080328 Address after: Liuyang, Hunan Province, north of the city of Li bridge, Hunan, Changsha mailbox Patentee after: Hunan Taier Pharmaceutical Company Limited Address before: Hunan City, Liuyang Province North set Li bridge, Changsha, Hunan mailbox Pharmaceutical Co., Ltd. Patentee before: Cheng Gang |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Blood fat-regulating liver-protecting health food Effective date of registration: 20150212 Granted publication date: 20070228 Pledgee: Bank of Beijing Limited by Share Ltd Changsha branch Pledgor: Hunan Taier Pharmaceutical Company Limited Registration number: 2015430000004 |
|
| PP01 | Preservation of patent right |
Effective date of registration: 20161107 Granted publication date: 20070228 |
|
| RINS | Preservation of patent right or utility model and its discharge | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20191107 Granted publication date: 20070228 |
|
| PD01 | Discharge of preservation of patent | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070228 Termination date: 20210518 |